NM_000059.4(BRCA2):c.2886T>C (p.His962=) AND Hereditary breast ovarian cancer syndrome
- Germline classification:
- Likely benign (1 submission)
- Last evaluated:
- Jan 24, 2024
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000918597.9
Allele description [Variation Report for NM_000059.4(BRCA2):c.2886T>C (p.His962=)]
NM_000059.4(BRCA2):c.2886T>C (p.His962=)
Condition(s)
- Name:
- Hereditary breast ovarian cancer syndrome
- Synonyms:
- Hereditary breast and ovarian cancer syndrome; Hereditary breast and ovarian cancer; Hereditary breast and ovarian cancer syndrome (HBOC); See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0003582; MeSH: D061325; MedGen: C0677776; Orphanet: 145
-
PREDICTED: Cucurbita maxima ATP-dependent 6-phosphofructokinase 7-like (LOC11149...
PREDICTED: Cucurbita maxima ATP-dependent 6-phosphofructokinase 7-like (LOC111498337), transcript variant X3, mRNAgi|1280981578|ref|XM_023149543.1|Nucleotide
-
Cardiovascular outcomes in high-risk patients without heart failure treated with...
Cardiovascular outcomes in high-risk patients without heart failure treated with ARBs: a systematic review and meta-analysis - Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews
-
Mus musculus RIKEN cDNA 4930532I03 gene (4930532I03Rik), transcript variant 2, l...
Mus musculus RIKEN cDNA 4930532I03 gene (4930532I03Rik), transcript variant 2, long non-coding RNAgi|765365502|ref|NR_131027.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024